Breaking News Instant updates and real-time market news.

TTWO

Take-Two

16:01
02/07/18
02/07
16:01
02/07/18
16:01

TakeTwo Interactive Software trading halted, news pending

  • 07

    Feb

  • 16

    Mar

TTWO Take-Two

02/01/18
02/01/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Epizyme (EPZM) initiated with a Buy at Roth Capital. 2. Take-Two (TTWO) initiated with an Overweight at Morgan Stanley. 3. AMERI Holdings (AMRH) initiated with an Outperform at Northland. 4. Simply Good Foods (SMPl) initiated with a Buy at SunTrust. 5. Zynerba (ZYNE) assumed with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/01/18
BARD
02/01/18
NO CHANGE
BARD
Outperform
Additional Red Dead delay doesn't mean trouble for Take-Two, says Baird
Baird analyst Colin Sebastian noted that Take-Two Interactive has announced the launch of "Red Dead Redemption 2" has been pushed out further, but he believes the quality of content is more important than hitting "somewhat arbitrary commercial deadlines" and this latest delay is the right move. In addition to the prospects for better game play and user satisfaction, the title could benefit incrementally from a holiday-period release, said the analyst, who continues to estimate 18M units sold for RDR2 in FY19. Sebastian keeps an Outperform rating on Take-Two shares.
02/01/18
PIPR
02/01/18
NO CHANGE
Target $125
PIPR
Overweight
Red Dead delay immaterial to Take-Two, says Piper Jaffray
Piper Jaffray analyst Michael Olson says the delay of Red Dead Redemption 2 until the fall will be immaterial to Take-Two Interactive. The company reiterated its fiscal 2019 guidance despite the delay, which is likely a sign of ongoing strength for GTA Online, Olson tells investors in a research note. He maintains an Overweight rating on Take-Two with a $125 price target.
02/02/18
OPCO
02/02/18
NO CHANGE
Target $135
OPCO
Outperform
Take-Two game delay does not impact estimates, says Oppenheimer
Oppenheimer analyst Andrew Uerkwitz says that while the Red Dead Redemption 2 delay is disappointing, he does not see it affecting his numbers or expectations for Take-Two Interactive. It is not out of the norm for Rockstar to delay games given its pursuit for the perfect title, Uerkwitz tells investors in a research note titled "Not 'On Shaky's Ground.'" The analyst is confident Red Dead Redemption 2 will remain the most anticipated game of the year. He keeps an Outperform rating on Take Two shares with a $135 price target.

TODAY'S FREE FLY STORIES

12:28
02/20/18
02/20
12:28
02/20/18
12:28
Conference/Events
Cantor analysts to hold an analyst/industry conference call »

Analysts, along with…

QTNA

Quantenna Communications

$14.10

0.01 (0.07%)

12:27
02/20/18
02/20
12:27
02/20/18
12:27
Conference/Events
Quantenna Communications management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 26

    Feb

  • 11

    Mar

BHP

BHP Billiton

$46.62

-2.07 (-4.25%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Downgrade
BHP Billiton rating change  »

BHP Billiton downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QNTA

Quanta Capital Hldgs

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Quanta Capital Hldgs management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$22.68

-0.06 (-0.26%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Options
Marvell call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 08

    Mar

MRVL

Marvell

$22.68

-0.06 (-0.26%)

, CAVM

Cavium

$87.16

-0.09 (-0.10%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Cavium to host special shareholder meeting »

Special Shareholder…

MRVL

Marvell

$22.68

-0.06 (-0.26%)

CAVM

Cavium

$87.16

-0.09 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 08

    Mar

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
UBS airlines analyst holds an analyst/industry conference call »

Analyst Genovesi, along…

SCI

Service Corp.

$38.65

-0.2 (-0.51%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Service Corp. to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 04

    Mar

WMT

Walmart

$95.22

-9.56 (-9.12%)

12:21
02/20/18
02/20
12:21
02/20/18
12:21
Recommendations
Walmart analyst commentary  »

Walmart e-commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

WMT

Walmart

$95.23

-9.55 (-9.11%)

, HD

Home Depot

$189.64

2.67 (1.43%)

12:17
02/20/18
02/20
12:17
02/20/18
12:17
General news
On The Fly: Top stock stories at midday »

Stocks opened deep in…

WMT

Walmart

$95.23

-9.55 (-9.11%)

HD

Home Depot

$189.64

2.67 (1.43%)

NXPI

NXP Semiconductors

$118.50

1.58 (1.35%)

QCOM

Qualcomm

$64.85

-0.43 (-0.66%)

AVGO

Broadcom

$248.89

-2.94 (-1.17%)

RAD

Rite Aid

$2.21

0.0801 (3.76%)

MDXG

MiMedx

$14.47

-0.96 (-6.22%)

UBNT

Ubiquiti

$74.04

-1.25 (-1.66%)

VYGR

Voyager Therapeutics

$19.36

0.19 (0.99%)

ABBV

AbbVie

$120.79

2.19 (1.85%)

FOGO

Fogo De Chao

$12.55

-0.15 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 14

    Mar

  • 18

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

$NSD

NASDAQ Market Internals

12:17
02/20/18
02/20
12:17
02/20/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
02/20/18
02/20
12:16
02/20/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$14.23

0.105 (0.74%)

12:15
02/20/18
02/20
12:15
02/20/18
12:15
Options
Vale put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFII

Electronics for Imaging

$28.11

0.04 (0.14%)

12:10
02/20/18
02/20
12:10
02/20/18
12:10
Conference/Events
Electronics for Imaging management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 13

    Mar

  • 14

    Mar

BHP

BHP Billiton

$46.89

-1.8 (-3.70%)

12:09
02/20/18
02/20
12:09
02/20/18
12:09
Downgrade
BHP Billiton rating change  »

BHP Billiton downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$41.63

-0.51 (-1.21%)

12:05
02/20/18
02/20
12:05
02/20/18
12:05
Options
Mylan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 13

    Nov

12:05
02/20/18
02/20
12:05
02/20/18
12:05
General news
Euro$ interest rate futures are mostly lower »

Euro$ interest rate…

SYNT

Syntel

$26.87

1.16 (4.51%)

12:03
02/20/18
02/20
12:03
02/20/18
12:03
Conference/Events
Syntel management to meet with Loop Capital »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

HSIC

Henry Schein

$69.52

1.14 (1.67%)

12:00
02/20/18
02/20
12:00
02/20/18
12:00
Downgrade
Henry Schein rating change  »

Henry Schein downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

12:00
02/20/18
02/20
12:00
02/20/18
12:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

GPS

Gap

$32.18

-1.0899 (-3.28%)

11:58
02/20/18
02/20
11:58
02/20/18
11:58
Recommendations
Gap analyst commentary  »

Jefferies remains buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 18

    Mar

HSIC

Henry Schein

$69.52

1.14 (1.67%)

11:55
02/20/18
02/20
11:55
02/20/18
11:55
Downgrade
Henry Schein rating change  »

Henry Schein downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OZM

Och-Ziff Capital

$2.56

-0.035 (-1.35%)

11:55
02/20/18
02/20
11:55
02/20/18
11:55
Conference/Events
CFA Society of Columbus to hold a luncheon meeting »

Group Luncheon with guest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

DBVT

DBV Technologies

$25.86

-0.29 (-1.11%)

, AIMT

Aimmune

$37.20

-1.04 (-2.72%)

11:54
02/20/18
02/20
11:54
02/20/18
11:54
Recommendations
DBV Technologies, Aimmune analyst commentary  »

DBV Technologies wins…

DBVT

DBV Technologies

$25.86

-0.29 (-1.11%)

AIMT

Aimmune

$37.20

-1.04 (-2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 02

    Mar

  • 11

    Mar

KEYW

KEYW

$7.51

0.01 (0.13%)

11:53
02/20/18
02/20
11:53
02/20/18
11:53
Conference/Events
KEYW management to meet with Maxim »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 15

    Mar

  • 14

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.